Relationship between plasma leptin levels and clinical outcomes of pediatric traumatic brain injury

Chao Lin1, Shou-Jiang Huang, Ning Wang

  • 1Department of Neurosurgery, The Children’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Peptides
|July 6, 2012
PubMed

Insights

Elevated plasma leptin levels in children with traumatic brain injury (TBI) predict mortality and poor outcomes. This finding suggests leptin is a novel biomarker for TBI prognosis in pediatric patients.

Area of Science:

  • Pediatric critical care medicine
  • Neurotrauma research
  • Biomarker discovery

Background:

  • High plasma leptin levels are linked to mortality in adult intracerebral hemorrhage.
  • The role of leptin in pediatric traumatic brain injury (TBI) outcomes is not well understood.

Purpose of the Study:

  • To investigate plasma leptin concentrations in children with TBI.
  • To analyze the correlation between leptin levels and TBI outcomes in pediatric patients.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to measure plasma leptin concentrations.
  • Study included 142 children with acute severe TBI and 89 healthy controls.
  • Logistic regression and ROC curve analysis assessed leptin's predictive value for 6-month outcomes.

Main Results:

  • Children with TBI had significantly higher plasma leptin levels upon admission compared to healthy controls.
  • Plasma leptin level was an independent predictor of 6-month mortality and unfavorable outcomes (Glasgow Outcome Scale 1-3).
  • Leptin demonstrated prognostic value comparable to the Glasgow Coma Scale score for predicting 6-month clinical outcomes.

Conclusions:

  • Plasma leptin level is a novel and effective biomarker for predicting 6-month mortality and unfavorable outcomes in children with TBI.
  • Leptin measurement offers a valuable tool for assessing prognosis in pediatric TBI.
  • Further research may elucidate the mechanisms underlying leptin's role in TBI pathophysiology.